Microneedles in Allergy Immunotherapy: the Present and Future

Area of Science:

• Allergy and Immunology
• Dermatology
• Nanotechnology in Medicine

Background:

• Conventional allergen-specific immunotherapy (AIT) methods like SCIT, SLIT, and OIT face challenges including adverse reactions and poor patient adherence.
• Current skin-targeted AIT approaches are limited by poor allergen penetration into the epidermis.

Purpose of the Study:

• To review limitations of current allergen-specific immunotherapy (AIT) methods.
• To introduce microneedles (MNs) as a transdermal platform for enhancing AIT.

Main Methods:

• Review of preclinical studies on microneedle-based transdermal immunotherapy (MN-TDIT).
• Analysis of MN-TDIT's allergen delivery into dermal layers and immune response modulation.

Main Results:

• MN-TDIT effectively delivers allergens to the dermis, enhancing immune responses and reducing allergic inflammation in preclinical models.
• MN-TDIT demonstrates improved immunogenicity, fewer side effects, and ease of administration compared to existing AIT strategies.

Conclusions:

• Microneedle-based transdermal immunotherapy (MN-TDIT) presents a promising strategy to improve AIT safety, efficacy, and patient adherence.
• Further research is needed to address formulation stability, optimize allergen release, and conduct clinical trials for MN-TDIT validation.